Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 3

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Pre-treatment gut microbiome and salivary metabolome signatures associate with chemotherapy-induced cognitive decline in women with breast cancer: A prospective pilot study

Cross, Courtney B., Bowen, Joanne M., Leifert, Wayne R., Beale, David J., Francois, Maxime, Joshi, Rohit, Fosh, Beverley G., Coller, Janet K., Tuke, Jonathan, Bareham, Monique, Cosier, Denelle J., To, Linh Hang, Ryan, Feargal J., Wardill, Hannah R.·2026·Cancer Letters
DOI 10.1016/j.canlet.2025.218234
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.canlet.2025.218234

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 13

  1. Ramsey, 2021, A core set of patient-reported outcomes for population-based cancer survivorship research: a consensus study, J. Cancer Surviv., 15, 201, 10.1007/s11764-020-00924-5 · DOI
  2. Whittaker, 2022, Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis, Sci. Rep., 12, 2135, 10.1038/s41598-022-05682-1 · DOI · Paper page
  3. Schrauwen, 2020, Heterogeneous response of chemotherapy-related cognitive decline in patients with breast cancer: a prospective study, J. Int. Neuropsychol. Soc., 26, 806, 10.1017/S1355617720000296 · DOI
  4. Miller, 2025, Gut microbiome signatures predict cognitive impairment in older cancer survivors, GeroScience, 10.1007/s11357-025-01917-x · DOI · Paper page
  5. Henneghan, 2021, Measuring self-reported cancer-related cognitive impairment: recommendations from the cancer neuroscience initiative working group, J. Natl. Cancer Inst., 113, 1625, 10.1093/jnci/djab027 · DOI
  6. Fardell, 2022, Screening for cognitive symptoms among cancer patients during chemotherapy: sensitivity and specificity of a single item self-report cognitive change score, Psychooncology, 31, 1294, 10.1002/pon.5928 · DOI
  7. Korver, 2023, Advanced statistics identification of participant and treatment predictors associated with severe adverse effects induced by fluoropyrimidine-based chemotherapy, Cancer Chemother. Pharmacol., 91, 507, 10.1007/s00280-023-04538-3 · DOI
  8. Callahan, 2016, DADA2: high-resolution sample inference from Illumina amplicon data, Nat. Methods, 13, 581, 10.1038/nmeth.3869 · DOI · Paper page
  9. Wirbel, 2024, A realistic benchmark for differential abundance testing and confounder adjustment in human microbiome studies, Genome Biol., 25, 247, 10.1186/s13059-024-03390-9 · DOI
  10. Beale, 2021, Metabolic profiling from an asymptomatic ferret model of SARS-CoV-2 infection, Metabolites, 11, 327, 10.3390/metabo11050327 · DOI
  11. Hurh, 1994, Microbial production of 6-hydroxynicotinic acid, an important building block for the synthesis of modern insecticides, J. Ferment. Bioeng., 77, 382, 10.1016/0922-338X(94)90008-6 · doi:10.1016/0922-338x(94)90008-6
  12. Dowdell, 2021, Metabolic host-microbiota interactions in autophagy and the pathogenesis of inflammatory bowel disease (IBD), Pharmaceuticals, 14, 10.3390/ph14080708 · DOI
  13. Moreno, 2014, Differential neuroprotective effects of 5′-Deoxy-5′-Methylthioadenosine, PLoS One, 9, 10.1371/journal.pone.0090671 · DOI

Metadata

Authors
Cross, C. B., Bowen, J. M., Leifert, W. R., Beale, D. J., Francois, M., Joshi, R., Fosh, B. G., Coller, J. K., Tuke, J., Bareham, M., Cosier, D. J., To, L. H., Ryan, F. J., & Wardill, H. R.
Venue
Cancer Letters
Publisher
Elsevier BV
Published
2026-03
Volume
640
Pages
218234
ISSN
0304-3835
DOI
10.1016/j.canlet.2025.218234
Cited by
3
References
2
Language
en
Licence
Funders
  • National Health and Medical Research Council
  • Hospital Research Foundation (2021/81-QA25313)
  • University of Adelaide
  • South Australian Health and Medical Research Institute

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pre-treatment gut microbiome and salivary metabolome signatures associate with chemotherapy-induced cognitive decline in women with breast cancer: A prospective pilot study. https://app.cochat.ai/papers/10.1016/j.canlet.2025.218234
The paper
Cross, C. B., Bowen, J. M., Leifert, W. R., Beale, D. J., Francois, M., Joshi, R., Fosh, B. G., Coller, J. K., Tuke, J., Bareham, M., Cosier, D. J., To, L. H., Ryan, F. J., & Wardill, H. R. (2026). Pre-treatment gut microbiome and salivary metabolome signatures associate with chemotherapy-induced cognitive decline in women with breast cancer: A prospective pilot study. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.218234

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.